Comment on “Reevaluating the Senolytic Activity of a GLS1 Inhibitor and an Anti-PD-1 Antibody: Toward Greater Reproducibility and Methodological Rigor” by Kawamoto et al.
Johmura et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: